FDA: Page 96


  • The FDA logo on a glass pane at the agency's campus in Silver Spring, Maryland.
    Image attribution tooltip
    Jacob Bell/MedTech Dive
    Image attribution tooltip

    Patient deaths following Getinge device shutdowns prompt FDA warning

    The agency has reports of three patient deaths following intra-aortic balloon pump malfunctions.

    By Nov. 2, 2018
  • Image attribution tooltip
    Roche
    Image attribution tooltip

    FDA warns about Roche test after reports of patient strokes

    Two patients suffered serious injuries involving strokes, prompting a warning that inaccurate results from the Swiss pharma's CoaguChek could cause serious injuries or death when taken with the blood thinner warfarin.

    By Nov. 2, 2018
  • Intuitive Surgical's da Vinci 5 robotic system. Explore the Trendline
    Image attribution tooltip
    Courtesy of Intuitive Surgical
    Image attribution tooltip
    Trendline

    Top 5 stories from MedTech Dive

    From the top medtech trends to watch in 2026 to haphazard layoffs at the Food and Drug Administration and the evolving use of AI in the medtech sector, here is a collection of top stories from MedTech Dive.

    By MedTech Dive staff
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Zimmer gets FDA nod for knee implant as portfolio strategy advances

    Clearance coincided with first use of the device maker's knee surgery robot. The CEO has been vague about how it will differentiate its knee and spine devices from rival products, such as those sold by Mazor Robotics and Stryker.

    By Nov. 1, 2018
  • 23andMe wins FDA clearance for first-of-its-kind genetic test

    The agency also sent a safety communication warning about the danger of relying on genetic tests that have not been reviewed by FDA making claims about patient response to individual medications.

    By David Lim , Nov. 1, 2018
  • A timeline of Anthem's bold payment policies (and the fallout)

    The payer's aggressive moves to push procedures like imaging to outpatient settings and taking a hard line on emergency room visits has drawn fire from doctors and other critics.​

    By Samantha Liss • Oct. 31, 2018
  • A picture of the exterior of the US Department of Health and Human Services. In front of the building is a black sign designating the building's name.
    Image attribution tooltip
    Alex Wong via Getty Images
    Image attribution tooltip

    HHS opens cybersecurity coordination center after troubled year

    It comes five months after a bipartisan group of lawmakers took HHS to task over stuttering attempts to coordinate cybersecurity information sharing.

    By Oct. 31, 2018
  • AdvaMed pitches new Anti-Kickback Statute safe harbors

    The trade group wants the carve-outs for value-based pricing, warranty and risk-sharing arrangements.

    By David Lim • Oct. 30, 2018
  • Deep Dive

    5 sticking points in the EU medical device reg transition

    Brexit and notified body capacity are among the uncertainties, as many in the medtech sector are uninformed.

    By Meg Bryant • Oct. 29, 2018
  • Speedy Medicare breakthrough device coverage plan slated for March

    AdvaMed has been pushing the agency to take steps to limit the delay between FDA approval and reimbursement. 

    By Oct. 26, 2018
  • Image attribution tooltip
    Elizabeth Regan/MedTech Dive
    Image attribution tooltip

    Novarad augmented reality system for surgery clears FDA

    The OpenSight system is designed for use with Microsoft HoloLens technology.

    By Meg Bryant • Oct. 25, 2018
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Medtronic's dose-controlling app for pain pump gets FDA nod

    The technology enables users to deliver doses on demand to cope with breakthrough pain.

    By Oct. 25, 2018
  • FDA clears Ansh Labs menopausal status test

    Physicians can use the results to inform actions to prevent osteoporosis and heart disease.

    By Oct. 25, 2018
  • Adverse events prompt FDA to advise monitoring of Alcon implants

    For now, the FDA says the problem looks to be limited to Alcon's implant. Glaukos markets a rival iStent device and saw its stock price increase by 40% when Alcon withdrew its stent.

    By Oct. 25, 2018
  • Image attribution tooltip
    MedImmune
    Image attribution tooltip

    LabCorp blames data breach, hurricane for substandard Q3

    The diagnostics branch was "particularly disappointing," said chairman and CEO Dave King.

    By Rebecca Pifer Parduhn • Oct. 24, 2018
  • FDA starts 510(k) pilot to cut optical tomography processing times

    The program aims to give developers of optical coherence tomography devices the chance to discuss premarket performance testing recommendations with the agency.

    By Oct. 24, 2018
  • Medtronic's low-profile thoracic endograft gets FDA nod

    By expanding TEVAR to patients with a broader range of anatomies, Medtronic could gain an edge over rivals Bolton Medical, Cook Medical and Gore Medical.

    By Oct. 24, 2018
  • Viseon gets 510(k) clearance for spinal surgery device

    The product enables visualization of surgical sites during minimally-invasive procedures.

    By Oct. 19, 2018
  • Image attribution tooltip
    Jacob Bell
    Image attribution tooltip

    FDA sets busy year-end medical device to-do list

    Improving mammography quality, revamping the De Novo classification process and revising the definition of a medical device to exclude certain medical software are some of the agency's priorities.

    By David Lim • Oct. 19, 2018
  • Image attribution tooltip
    Fotolia
    Image attribution tooltip

    Stakeholders call for transparency, ease of use in EHR Reporting Program

    In comments, several healthcare organizations requested a centralized clearinghouse of existing health IT comparison resources.

    By Meg Bryant • Oct. 18, 2018
  • FDA targets late 2019 for hearing aid proposed rule

    The plan comes two weeks after Bose won clearance to sell the first self-fitting hearing aid that can be programmed without the help of a healthcare provider.

    By David Lim • Oct. 18, 2018
  • Image attribution tooltip
    Credit: Andrew Propp, FDA / Edited by BioPharma Dive
    Image attribution tooltip

    FDA floats changes to cybersecurity guidance to strengthen safeguards

    Proposals include creation of lists of all hardware and software components used in a device that could be vulnerable to attack.

    By Oct. 18, 2018
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    FDA boosts medical device cybersecurity coordination with Homeland Security

    The DHS Office of Cybersecurity and Communications and FDA's device center will increase information sharing of potential and confirmed device vulnerabilities and threats.

    By David Lim • Oct. 16, 2018
  • Anthem shells out $16M to settle biggest health data breach in history

    The fund will pay for four years of credit monitoring and all other claims, costs and fees for affected individuals, according to the settlement. 

    By Rebecca Pifer Parduhn • Oct. 16, 2018
  • Image attribution tooltip
    Jacob Bell
    Image attribution tooltip

    Endologix recalls cardiac implants amid ongoing rupture risk

    The Class I recall stems from reports of some devices failing to divert blood away from aneurysms.

    By Oct. 16, 2018
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Blue Button 2.0 doubles developers to 1,200, but beneficiary uptake tiny

    CMS Administrator Seema Verma tells MedTech Dive that 11 organizations have "production apps" in place using live data.

    By David Lim • Oct. 15, 2018